Advertisement

Topics

"Ovid Therapeutics Reports Third Quarter 2017 Financial Results" Drugs and Medication Database: Page 3

15:19 EDT 20th March 2019 | BioPortfolio

Here are the most relevant "Ovid Therapeutics Reports Third Quarter 2017 Financial Results" Drugs and Medications that we have found in our database.

More Information about "Ovid Therapeutics Reports Third Quarter 2017 Financial Results" on BioPortfolio

We have published hundreds of Ovid Therapeutics Reports Third Quarter 2017 Financial Results news stories on BioPortfolio along with dozens of Ovid Therapeutics Reports Third Quarter 2017 Financial Results Clinical Trials and PubMed Articles about Ovid Therapeutics Reports Third Quarter 2017 Financial Results for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ovid Therapeutics Reports Third Quarter 2017 Financial Results Companies in our database. You can also find out about relevant Ovid Therapeutics Reports Third Quarter 2017 Financial Results Drugs and Medications on this site too.

Showing "Ovid Therapeutics Reports Third Quarter 2017 Financial Results" Drugs and Medications 51–57 of 57

Possibly Relevant

Aripiprazole [remedyrepack inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [torrent pharmaceuticals limited]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [preferred pharmaceuticals inc.]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [major pharmaceuticals]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Luxturna [spark therapeutics, inc.]

These highlights do not include all the information needed to use LUXTURNA safely and effectively. See full prescribing information for LUXTURNA.LUXTURNA (voretigene neparvovec-rzyl) intraocular suspension for subretinal injectionInitial U.S. Approval: 20

Aripiprazole [bryant ranch prepack]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002

Aripiprazole [denton pharma, inc. dba northwind pharmaceuticals]

These highlights do not include all the information needed to use ARIPIPRAZOLE TABLETS safely and effectively. See full prescribing information for ARIPIPRAZOLE TABLETS. ARIPIPRAZOLE tablets, for oral use Initial U.S. Approval: 2002



Advertisement
Quick Search
Advertisement
Advertisement